Who are the highest risk patients and how do we manage them?
- Dan Gaita, Romania
Chronic kidney disease patients
Colin Baigent, Oxford, UK
Acute coronary syndrome patients
Jose Luis Zamorano, Spain
Controversies in nutrition
- Evangelos Liberopoulos, Greece
To what extent can functional ingredients and supplements that lower LDL-C play a role in CVD risk management?
Sabine Baumgartner, The Netherlands
Which diet works best for cardiovascular prevention?
Sun Qi, USA
Lipid lowering therapies from childhood to old age
- Steve Humphries, UK
Treating primary dyslipidemia in children: what we’ve learned from treating patients with Familial Hypercholesterolemia
Marina Cuchel, USA
Strategies towards personalized risk stratification
- Ionna Gouni-Berthold, Germany
Refinement of risk prediction by imaging
Paolo Raggi, Alberta, Canada
Refinement of risk prediction by circulating biomarkers
Stefan Blankenberg, Germany
Non coding RNA and epigenetic regulators
- Christina Christoffersen, Denmark
The multifactorial nature of microRNAs in vascular remodelling
Yael Nossent, Vienna, Austria
High-resolution regulatory maps connect vascular risk variants to disease-related pathways
Pelin Sahlén, Sweden
Immune cells in the arterial wall
- Christoph Binder, Austria
Inflammasome, neutrophil extracellular traps and cholesterol
Marit Westerterp, Groningen, The Netherlands
Transcriptomic landscape and heterogeneity of macrophages in atherosclerosis.
Alma Zernecke, Würzburg, Germany
Lipoproteins and the arterial wall
- Winfried März, Germany
LDL aggregation
Katariina Öörni, Helsinki, Finland
Transendothelial transport
Philip Shaul, USA
Plaque rupture and erosion
- Margus Viigimaa, Estonia
Microvesicles and endothelial activation
Lina Badimon, Barcelona, Spain
Vulnerable plaque: Current concepts in pathophysiology and imaging
Oliver Soehnlein, Munich, Germany
Lipoprotein receptors and lipid transport
- Noam Zelcer, The Netherlands
Role of the retromer COMMD/WASH complex
Bart van de Sluis, Groningen, The Netherlands
Lipoprotein transport in the brain
Francesca Zimetti, Parma, Italy
Sterols at the crossroad of metabolic pathways
- Xavier Collet, France
The role of FXR in reverse cholesterol transport
Folkert Kuipers, Groningen, The Netherlands
G-protein coupled bile acid receptors
Elena Osto, Czech Republic
Metabolic control of fat storage and combustion
- Patrick Rensen, The Netherlands
Browning of white adipose tissue
Alexander Bartelt, Germany
Whitening of brown adipose tissue - role of the mevalonate pathwa
Christian Wolfrum, Zürich, Switzerland
Cellular lipid trafficking
- Bart Staels, France
Intracellular cholesterol trafficking
Elina Ikonen, Helsinki, Finland
Impact of lipid droplets - implications for human disease
Tobias Walther, USA
Bob Farese, USA